Synchrocast: Understanding Brexit and its Impact on Patients
Synchrogenix's Darshan Kulkarni, Vice President, Regulatory Strategy and Policy, and Nirpal Virdee, Director, Client Services and Technology, talk about Brexit and its impact on patients. Listen in (or read the transcript) to learn more about Brexit, including the reasons behind the binary public referendum put to the United Kingdom's citizens back in 2016, and the outcome of the voting results. After providing thorough Brexit background, Darshan and Nirpal dive into Brexit's impact on the pharmaceutical industry and patients.
Listen to the Synchrocast
Download the transcript